The antiviral drug, “Molnupiravir" as treatment for mild and moderate coronavirus disease (COVID-19) cases is now on Phase 3 clinical trial at the Lung Center of the Philippines. (Facebook/MANILA BULLETIN FILE PHOTO) The clinical trial started on May 17 this year and has enrolled a total of 11...